# Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

> **NCT00170989** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 2714 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan plus hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00170989
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 2714 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00170989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00170989, "Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00170989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*